Relationship between Vitamin D status and microbiome changes in Bulgarian patients with type 2 diabetes mellitus

References

• Wang PX, Deng XR, Zhang CH, et al. Gut microbiota and metabolic syndrome. Chin Med J (Engl). 2020;133(7):1–8.
   PubMed Web of Science ®Google Scholar
• Salonen A, Lahti L, Salojärvi J, et al. Impact of diet and individual variation on intestinal microbiota composition and fermentation products in obese men. ISME J. 2014;8(11):2218–2230.
   PubMed Web of Science ®Google Scholar
• Sanz Y, Olivares M, Moya-Pérez Á, et al. Understanding the role of gut microbiome in metabolic disease risk. Pediatr Res. 2015;77(1-2):236–244. Epub 2014 Oct 14. PMID: 25314581.
   PubMed Web of Science ®Google Scholar
• Caesar R, Reigstad CS, Bäckhed HK, et al. Gut-derived lipopolysaccharide augments adipose macrophage accumulation but is not essential for impaired glucose or insulin tolerance in mice. Gut. 2012;61(12):1701–1707.
   PubMed Web of Science ®Google Scholar
• Al-Khaldy NS, Al-Musharaf S, Aljazairy EA, et al. Serum vitamin D level and gut microbiota in women. Healthcare (Basel). 2023;11(3):351.
   PubMedGoogle Scholar
• Charoenngam N, Shirvani A, Kalajian TA, et al. The effect of various doses of oral vitamin D3 supplementation on gut microbiota in healthy adults: a randomized, double-blinded, dose-response study. Anticancer Res. 2020;40(1):551–556.
   PubMed Web of Science ®Google Scholar
• Waterhouse M, Hope B, Krause L, et al. Vitamin d and the gut microbiome: a systematic review of in vivo studies. Eur J Nutr. 2019;58(7):2895–2910.
   PubMed Web of Science ®Google Scholar
• Aranow C. Vitamin d and the immune system. J Investig Med. 2011;59(6):881–886.
   PubMed Web of Science ®Google Scholar
• Weiss ST. Bacterial components plus vitamin D: the ultimate solution to the asthma (autoimmune disease) epidemic? J Allergy Clin Immunol. 2011;127(5):1128–1130.
   PubMed Web of Science ®Google Scholar
• Gérard C, Vidal H. Impact of gut microbiota on host glycemic control. Front Endocrinol (Lausanne). 2019;10:29.
   PubMed Web of Science ®Google Scholar
• Malla MA, Dubey A, Kumar A, et al. Exploring the human microbiome: the potential future role of next-generation sequencing in disease diagnosis and treatment. Front Immunol. 2018;9:2868.
   PubMed Web of Science ®Google Scholar
• Fan Y, Pedersen O. Gut microbiota in human metabolic health and disease. Nat Rev Microbiol. 2021;19(1):55–71.
   PubMed Web of Science ®Google Scholar
• Filipov JJ, Petrova M, Metodieva T, et al. Vitamin D influences the prevalence of non-cutaneous carcinomas after kidney transplantation? Biotechnol Biotechnol Equip. 2018;32(5):1266–1270.
   Web of Science ®Google Scholar
• Qin J, Li R, Raes J, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature. 2010;464(7285):59–65.
   PubMed Web of Science ®Google Scholar
• Magne F, Gotteland M, Gauthier L, et al. The firmicutes/bacteroidetes ratio: a relevant marker of gut dysbiosis in obese patients? Nutrients. 2020;12(5):1474.
   PubMed Web of Science ®Google Scholar
• Parada Venegas D, De la Fuente MK, Landskron G, et al. Short chain fatty acids (SCFAs)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases. Front Immunol. 2019;10:277. Erratum in: front Immunol. 2019;10:1486.
   PubMed Web of Science ®Google Scholar
• Yip W, Hughes MR, Li Y, et al. Butyrate shapes immune cell fate and function in allergic asthma. Front Immunol. 2021;12:628453.
   PubMed Web of Science ®Google Scholar
• Ciubotaru I, Green SJ, Kukreja S, et al. Significant differences in fecal microbiota are associated with various stages of glucose tolerance in African American male veterans. Transl Res. 2015;166(5):401–411.
   PubMed Web of Science ®Google Scholar
• Gorvitovskaia A, Holmes SP, Huse SM. Interpreting Prevotella and Bacteroides as biomarkers of diet and lifestyle. Microbiome. 2016;4:15. 10.1186/s40168-016-0160-7.
   PubMed Web of Science ®Google Scholar
• Kovatcheva-Datchary P, Nilsson A, Akrami R, et al. Dietary fiber-induced improvement in glucose metabolism is associated with increased abundance of Prevotella. Cell Metab. 2015;22(6):971–982.
   PubMed Web of Science ®Google Scholar
• Leite AZ, Rodrigues NC, Gonzaga MI, et al. Detection of increased plasma interleukin-6 levels and prevalence of Prevotella copri and Bacteroides vulgatus in the feces of type 2 diabetes patients. Front Immunol. 2017;8:1107.
   PubMed Web of Science ®Google Scholar
• Evivie SE, Huo GC, Igene JO, et al. Some current applications, limitations and future perspectives of lactic acid bacteria as probiotics. Food Nutr Res. 2017;61(1):1318034.
   PubMed Web of Science ®Google Scholar
• Thomas RL, Jiang L, Adams JS, et al. Vitamin D metabolites and the gut microbiome in older men. Nat Commun. 2020; 11(1):5997.
   PubMed Web of Science ®Google Scholar
• De Filippis F, Pasolli E, Ercolini D. The food-gut axis: lactic acid bacteria and their link to food, the gut microbiome and human health. FEMS Microbiol Rev. 2020;44(4):454–489.
   PubMed Web of Science ®Google Scholar
• Karlsson FH, Tremaroli V, Nookaew I, et al. Gut metagenome in european women with normal, impaired and diabetic glucose control. Nature. 2013;498(7452):99–103.
   PubMed Web of Science ®Google Scholar
• Forslund K, Hildebrand F, Nielsen T, MetaHIT consortium, et al. Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota. Nature. 2015;528(7581):262–266. Epub 2015 Dec 2. Erratum in: nature. 2017;545(7652):116.
   PubMed Web of Science ®Google Scholar
• Teixeira TS, Grześkowiak LM, Salminen S, et al. Faecal levels of bifidobacterium and Clostridium coccoides but not plasma lipopolysaccharide are inversely related to insulin and HOMA index in women. Clin Nutr. 2013;32(6):1017–1022.
   PubMed Web of Science ®Google Scholar
• Ignacio A, Fernandes MR, Rodrigues VA, et al. Correlation between body mass index and faecal microbiota from children. Clin Microbiol Infect. 2016;22(3):258.e1-8–258.e8.
   PubMed Web of Science ®Google Scholar
• Delzenne NM, Cani PD, Everard A, et al. Gut microorganisms as promising targets for the management of type 2 diabetes. Diabetologia. 2015;58(10):2206–2217.
   PubMed Web of Science ®Google Scholar
• Page MJ, Kell DB, Pretorius E. The role of lipopolysaccharide-induced cell signalling in chronic inflammation. Chronic Stress. 2022;6:247054702210763.
   Google Scholar
• Mohammad S, Thiemermann C. Role of metabolic endotoxemia in systemic inflammation and potential interventions. Front Immunol. 2020;11:594150.
   PubMed Web of Science ®Google Scholar
• Dordević D, Jančíková S, Vítězová M, et al. Hydrogen sulfide toxicity in the gut environment: meta-analysis of sulfate-reducing and lactic acid bacteria in inflammatory processes. J Adv Res. 2021;27:55–69.
   PubMed Web of Science ®Google Scholar
• Cesario V, Di Rienzo TA, Campanale M, et al. Methane intestinal production and poor metabolic control in type I diabetes complicated by autonomic neuropathy. Minerva Endocrinol. 2014;39(3):201–207. PMID: 25068305.
   PubMed Web of Science ®Google Scholar
• Akimbekov NS, Digel I, Sherelkhan DK, et al. Vitamin D and the host-gut microbiome: a brief overview. Acta Histochem Cytochem. 2020;53(3):33–42.
   PubMed Web of Science ®Google Scholar
• Yamamoto EA, Jørgensen TN. Relationships between vitamin D, gut microbiome, and systemic autoimmunity. Front Immunol. 2019;10:3141.
   PubMed Web of Science ®Google Scholar
• Qin J, Li Y, Cai Z, et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature. 2012;490(7418):55–60.
   PubMed Web of Science ®Google Scholar
• Dimova I, Yanachkova V, Boneva T, et al. Microbiome characterization in type 2 diabetes mellitus-relation to vitamin D levels. Diabetes Technol Ther. 2022;24: A186–A186.
   Web of Science ®Google Scholar